<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1987-08-13" modified="2017-05-10" version="224">
<accession>P04626</accession>
<accession>B2RZG3</accession>
<accession>B4DHN3</accession>
<accession>Q14256</accession>
<accession>Q6LDV1</accession>
<accession>Q9UMK4</accession>
<accession>X5D2V5</accession>
<name>ERBB2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Receptor tyrosine-protein kinase erbB-2</fullName>
<ecNumber>2.7.10.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Metastatic lymph node gene 19 protein</fullName>
<shortName>MLN 19</shortName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene Neu</fullName>
</alternativeName>
<alternativeName>
<fullName>Proto-oncogene c-ErbB-2</fullName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine kinase-type cell surface receptor HER2</fullName>
</alternativeName>
<alternativeName>
<fullName>p185erbB2</fullName>
</alternativeName>
<cdAntigenName>CD340</cdAntigenName>
</protein>
<gene>
<name type="primary">ERBB2</name>
<name type="synonym">HER2</name>
<name type="synonym">MLN19</name>
<name type="synonym">NEU</name>
<name type="synonym">NGL</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1986" name="Nature" volume="319" first="230" last="234">
<title>Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor.</title>
<authorList>
<person name="Yamamoto T."/>
<person name="Ikawa S."/>
<person name="Akiyama T."/>
<person name="Semba K."/>
<person name="Nomura N."/>
<person name="Miyajima N."/>
<person name="Saito T."/>
<person name="Toyoshima K."/>
</authorList>
<dbReference type="PubMed" id="3003577"/>
<dbReference type="DOI" id="10.1038/319230a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1985" name="Science" volume="230" first="1132" last="1139">
<title>Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene.</title>
<authorList>
<person name="Coussens L."/>
<person name="Yang-Feng T.L."/>
<person name="Liao Y.C."/>
<person name="Chen E."/>
<person name="Gray A."/>
<person name="McGrath J."/>
<person name="Seeburg P.H."/>
<person name="Libermann T.A."/>
<person name="Schlessinger J."/>
<person name="Francke U."/>
<person name="Levinson A."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="2999974"/>
<dbReference type="DOI" id="10.1126/science.2999974"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1)</scope>
<scope>VARIANT ALA-1170</scope>
</reference>
<reference key="3">
<citation type="submission" date="2002-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS CYS-452; VAL-655 AND ALA-1170</scope>
</reference>
<reference key="4">
<citation type="submission" date="2007-10" db="EMBL/GenBank/DDBJ databases">
<title>NEDO human cDNA sequencing project focused on splicing variants.</title>
<authorList>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Ishii S."/>
<person name="Watanabe K."/>
<person name="Sugiyama A."/>
<person name="Murakawa K."/>
<person name="Kaida T."/>
<person name="Tsuchiya K."/>
<person name="Fukuzumi Y."/>
<person name="Kumagai A."/>
<person name="Oishi Y."/>
<person name="Yamamoto S."/>
<person name="Ono Y."/>
<person name="Komori Y."/>
<person name="Yamazaki M."/>
<person name="Kisu Y."/>
<person name="Nishikawa T."/>
<person name="Sugano S."/>
<person name="Nomura N."/>
<person name="Isogai T."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1987" name="Mol. Cell. Biol." volume="7" first="2597" last="2601">
<title>Human HER2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation.</title>
<authorList>
<person name="Tal M."/>
<person name="King C.R."/>
<person name="Kraus M.H."/>
<person name="Ullrich A."/>
<person name="Schlessinger J."/>
<person name="Givol D."/>
</authorList>
<dbReference type="PubMed" id="3039351"/>
<dbReference type="DOI" id="10.1128/MCB.7.7.2597"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-191 (ISOFORM 1)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="3650" last="3650">
<title>Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism.</title>
<authorList>
<person name="Corominas R."/>
<person name="Yang X."/>
<person name="Lin G.N."/>
<person name="Kang S."/>
<person name="Shen Y."/>
<person name="Ghamsari L."/>
<person name="Broly M."/>
<person name="Rodriguez M."/>
<person name="Tam S."/>
<person name="Wanamaker S.A."/>
<person name="Fan C."/>
<person name="Yi S."/>
<person name="Tasan M."/>
<person name="Lemmens I."/>
<person name="Kuang X."/>
<person name="Zhao N."/>
<person name="Malhotra D."/>
<person name="Michaelson J.J."/>
<person name="Vacic V."/>
<person name="Calderwood M.A."/>
<person name="Roth F.P."/>
<person name="Tavernier J."/>
<person name="Horvath S."/>
<person name="Salehi-Ashtiani K."/>
<person name="Korkin D."/>
<person name="Sebat J."/>
<person name="Hill D.E."/>
<person name="Hao T."/>
<person name="Vidal M."/>
<person name="Iakoucheva L.M."/>
</authorList>
<dbReference type="PubMed" id="24722188"/>
<dbReference type="DOI" id="10.1038/ncomms4650"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 1-867 (ISOFORM 6)</scope>
<source>
<tissue>Fetal brain</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1985" name="Proc. Natl. Acad. Sci. U.S.A." volume="82" first="6497" last="6501">
<title>A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.</title>
<authorList>
<person name="Semba K."/>
<person name="Kamata N."/>
<person name="Toyoshima K."/>
<person name="Yamamoto T."/>
</authorList>
<dbReference type="PubMed" id="2995967"/>
<dbReference type="DOI" id="10.1073/pnas.82.19.6497"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 737-1031</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1985" name="Science" volume="229" first="974" last="976">
<title>Amplification of a novel v-erbB-related gene in a human mammary carcinoma.</title>
<authorList>
<person name="King C.R."/>
<person name="Kraus M.H."/>
<person name="Aaronson S.A."/>
</authorList>
<dbReference type="PubMed" id="2992089"/>
<dbReference type="DOI" id="10.1126/science.2992089"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 832-909</scope>
<source>
<tissue>Mammary carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1993" name="DNA Cell Biol." volume="12" first="611" last="615">
<title>Molecular cloning and sequencing of an intron of Her-2/neu (ERBB2) gene.</title>
<authorList>
<person name="Sarkar F.H."/>
<person name="Ball D.E."/>
<person name="Li Y.W."/>
<person name="Crissman J.D."/>
</authorList>
<dbReference type="PubMed" id="8104414"/>
<dbReference type="DOI" id="10.1089/dna.1993.12.611"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE OF 1081-1245</scope>
<scope>VARIANT ALA-1170</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="17209" last="17218">
<title>ErbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases.</title>
<authorList>
<person name="Olayioye M.A."/>
<person name="Beuvink I."/>
<person name="Horsch K."/>
<person name="Daly J.M."/>
<person name="Hynes N.E."/>
</authorList>
<dbReference type="PubMed" id="10358079"/>
<dbReference type="DOI" id="10.1074/jbc.274.24.17209"/>
</citation>
<scope>INTERACTION WITH ERBB4</scope>
<scope>FUNCTION IN ACTIVATION OF STAT5A</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="3817" last="3830">
<title>Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.</title>
<authorList>
<person name="Arcaro A."/>
<person name="Zvelebil M.J."/>
<person name="Wallasch C."/>
<person name="Ullrich A."/>
<person name="Waterfield M.D."/>
<person name="Domin J."/>
</authorList>
<dbReference type="PubMed" id="10805725"/>
<dbReference type="DOI" id="10.1128/MCB.20.11.3817-3830.2000"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH PIK3C2A AND EGFR</scope>
<scope>IDENTIFICATION IN A COMPLEX WITH PIK3C2B AND EGFR</scope>
<scope>INTERACTION WITH PIK3C2B</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Mol. Cancer Res." volume="1" first="765" last="775">
<title>Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein.</title>
<authorList>
<person name="Li Y."/>
<person name="Yu W.-H."/>
<person name="Ren J."/>
<person name="Chen W."/>
<person name="Huang L."/>
<person name="Kharbanda S."/>
<person name="Loda M."/>
<person name="Kufe D."/>
</authorList>
<dbReference type="PubMed" id="12939402"/>
</citation>
<scope>INTERACTION WITH MUC1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Cancer Cell" volume="6" first="251" last="261">
<title>Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2.</title>
<authorList>
<person name="Wang S.C."/>
<person name="Lien H.C."/>
<person name="Xia W."/>
<person name="Chen I.F."/>
<person name="Lo H.W."/>
<person name="Wang Z."/>
<person name="Ali-Seyed M."/>
<person name="Lee D.F."/>
<person name="Bartholomeusz G."/>
<person name="Ou-Yang F."/>
<person name="Giri D.K."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="15380516"/>
<dbReference type="DOI" id="10.1016/j.ccr.2004.07.012"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="J. Cell Biol." volume="165" first="869" last="880">
<title>Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2.</title>
<authorList>
<person name="Swiercz J.M."/>
<person name="Kuner R."/>
<person name="Offermanns S."/>
</authorList>
<dbReference type="PubMed" id="15210733"/>
<dbReference type="DOI" id="10.1083/jcb.200312094"/>
</citation>
<scope>INTERACTION WITH PLXNB1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="Nat. Cell Biol." volume="6" first="515" last="522">
<title>Memo mediates ErbB2-driven cell motility.</title>
<authorList>
<person name="Marone R."/>
<person name="Hess D."/>
<person name="Dankort D."/>
<person name="Muller W.J."/>
<person name="Hynes N.E."/>
<person name="Badache A."/>
</authorList>
<dbReference type="PubMed" id="15156151"/>
<dbReference type="DOI" id="10.1038/ncb1134"/>
</citation>
<scope>INTERACTION WITH MEMO1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Mol. Cell. Biol." volume="25" first="11005" last="11018">
<title>Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor.</title>
<authorList>
<person name="Giri D.K."/>
<person name="Ali-Seyed M."/>
<person name="Li L.Y."/>
<person name="Lee D.F."/>
<person name="Ling P."/>
<person name="Bartholomeusz G."/>
<person name="Wang S.C."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="16314522"/>
<dbReference type="DOI" id="10.1128/MCB.25.24.11005-11018.2005"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEAR LOCALIZATION SIGNAL</scope>
<scope>INTERACTION WITH KPNB1; RANBP2; CRM1; EEA1 AND CLTC</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1248</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="3234" last="3244">
<title>Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation.</title>
<authorList>
<person name="Anido J."/>
<person name="Scaltriti M."/>
<person name="Bech Serra J.J."/>
<person name="Santiago Josefat B."/>
<person name="Todo F.R."/>
<person name="Baselga J."/>
<person name="Arribas J."/>
</authorList>
<dbReference type="PubMed" id="16794579"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601191"/>
</citation>
<scope>FUNCTION</scope>
<scope>ALTERNATIVE INITIATION (ISOFORMS 2 AND 3)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF MET-611; MET-687; MET-706 AND MET-712</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Cell. Signal." volume="19" first="466" last="471">
<title>Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.</title>
<authorList>
<person name="Li Z."/>
<person name="Mei Y."/>
<person name="Liu X."/>
<person name="Zhou M."/>
</authorList>
<dbReference type="PubMed" id="16978839"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2006.07.020"/>
</citation>
<scope>INTERACTION WITH ERBB4</scope>
<scope>AUTOPHOSPHORYLATION IN TRANS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="J. Neurosci." volume="27" first="6333" last="6347">
<title>Plexin-B2, but not Plexin-B1, critically modulates neuronal migration and patterning of the developing nervous system in vivo.</title>
<authorList>
<person name="Deng S."/>
<person name="Hirschberg A."/>
<person name="Worzfeld T."/>
<person name="Penachioni J.Y."/>
<person name="Korostylev A."/>
<person name="Swiercz J.M."/>
<person name="Vodrazka P."/>
<person name="Mauti O."/>
<person name="Stoeckli E.T."/>
<person name="Tamagnone L."/>
<person name="Offermanns S."/>
<person name="Kuner R."/>
</authorList>
<dbReference type="PubMed" id="17554007"/>
<dbReference type="DOI" id="10.1523/JNEUROSCI.5381-06.2007"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1248</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1054</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1054</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="12463" last="12468">
<title>Brk is coamplified with ErbB2 to promote proliferation in breast cancer.</title>
<authorList>
<person name="Xiang B."/>
<person name="Chatti K."/>
<person name="Qiu H."/>
<person name="Lakshmi B."/>
<person name="Krasnitz A."/>
<person name="Hicks J."/>
<person name="Yu M."/>
<person name="Miller W.T."/>
<person name="Muthuswamy S.K."/>
</authorList>
<dbReference type="PubMed" id="18719096"/>
<dbReference type="DOI" id="10.1073/pnas.0805009105"/>
</citation>
<scope>INTERACTION WITH PTK6</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2009" name="Mol. Cancer Res." volume="7" first="592" last="600">
<title>ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.</title>
<authorList>
<person name="Hawthorne V.S."/>
<person name="Huang W.C."/>
<person name="Neal C.L."/>
<person name="Tseng L.M."/>
<person name="Hung M.C."/>
<person name="Yu D."/>
</authorList>
<dbReference type="PubMed" id="19372587"/>
<dbReference type="DOI" id="10.1158/1541-7786.MCR-08-0316"/>
</citation>
<scope>FUNCTION IN NUCLEUS</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Oncogene" volume="29" first="1598" last="1610">
<title>Copine-III interacts with ErbB2 and promotes tumor cell migration.</title>
<authorList>
<person name="Heinrich C."/>
<person name="Keller C."/>
<person name="Boulay A."/>
<person name="Vecchi M."/>
<person name="Bianchi M."/>
<person name="Sack R."/>
<person name="Lienhard S."/>
<person name="Duss S."/>
<person name="Hofsteenge J."/>
<person name="Hynes N.E."/>
</authorList>
<dbReference type="PubMed" id="20010870"/>
<dbReference type="DOI" id="10.1038/onc.2009.456"/>
</citation>
<scope>INTERACTION WITH CPNE3</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="18517" last="18522">
<title>ErbB2 receptor controls microtubule capture by recruiting ACF7 to the plasma membrane of migrating cells.</title>
<authorList>
<person name="Zaoui K."/>
<person name="Benseddik K."/>
<person name="Daou P."/>
<person name="Salaun D."/>
<person name="Badache A."/>
</authorList>
<dbReference type="PubMed" id="20937854"/>
<dbReference type="DOI" id="10.1073/pnas.1000975107"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1107</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="29" last="39">
<title>Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing.</title>
<authorList>
<person name="Zang Z.J."/>
<person name="Ong C.K."/>
<person name="Cutcutache I."/>
<person name="Yu W."/>
<person name="Zhang S.L."/>
<person name="Huang D."/>
<person name="Ler L.D."/>
<person name="Dykema K."/>
<person name="Gan A."/>
<person name="Tao J."/>
<person name="Lim S."/>
<person name="Liu Y."/>
<person name="Futreal P.A."/>
<person name="Grabsch H."/>
<person name="Furge K.A."/>
<person name="Goh L.K."/>
<person name="Rozen S."/>
<person name="Teh B.T."/>
<person name="Tan P."/>
</authorList>
<dbReference type="PubMed" id="21097718"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-1749"/>
</citation>
<scope>CHROMOSOMAL REARRANGEMENT WITH CDK12</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Cancer Res." volume="71" first="4269" last="4279">
<title>Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes.</title>
<authorList>
<person name="Li L.Y."/>
<person name="Chen H."/>
<person name="Hsieh Y.H."/>
<person name="Wang Y.N."/>
<person name="Chu H.J."/>
<person name="Chen Y.H."/>
<person name="Chen H.Y."/>
<person name="Chien P.J."/>
<person name="Ma H.T."/>
<person name="Tsai H.C."/>
<person name="Lai C.C."/>
<person name="Sher Y.P."/>
<person name="Lien H.C."/>
<person name="Tsai C.H."/>
<person name="Hung M.C."/>
</authorList>
<dbReference type="PubMed" id="21555369"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-10-3504"/>
</citation>
<scope>FUNCTION IN NUCLEUS</scope>
<scope>INTERACTION WITH ACTB AND RPA194</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="Endocrinology" volume="152" first="931" last="945">
<title>Dissociation of epidermal growth factor receptor and ErbB2 heterodimers in the presence of somatostatin receptor 5 modulate signaling pathways.</title>
<authorList>
<person name="Kharmate G."/>
<person name="Rajput P.S."/>
<person name="Watt H.L."/>
<person name="Somvanshi R.K."/>
<person name="Chaudhari N."/>
<person name="Qiu X."/>
<person name="Kumar U."/>
</authorList>
<dbReference type="PubMed" id="21190959"/>
<dbReference type="DOI" id="10.1210/en.2010-0940"/>
</citation>
<scope>INTERACTION WITH EGFR</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1054</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-182; SER-1054; SER-1083 AND THR-1166</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1054 AND SER-1151</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0141786" last="E0141786">
<title>Client proteins and small molecule inhibitors display distinct binding preferences for constitutive and stress-induced HSP90 isoforms and their conformationally restricted mutants.</title>
<authorList>
<person name="Prince T.L."/>
<person name="Kijima T."/>
<person name="Tatokoro M."/>
<person name="Lee S."/>
<person name="Tsutsumi S."/>
<person name="Yim K."/>
<person name="Rivas C."/>
<person name="Alarcon S."/>
<person name="Schwartz H."/>
<person name="Khamit-Kush K."/>
<person name="Scroggins B.T."/>
<person name="Beebe K."/>
<person name="Trepel J.B."/>
<person name="Neckers L."/>
</authorList>
<dbReference type="PubMed" id="26517842"/>
<dbReference type="DOI" id="10.1371/journal.pone.0141786"/>
</citation>
<scope>INTERACTION WITH HSP90AA1 AND HSP90AB1</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2016" name="Cell Rep." volume="15" first="1345" last="1358">
<title>Crystal structure and substrate specificity of PTPN12.</title>
<authorList>
<person name="Li H."/>
<person name="Yang F."/>
<person name="Liu C."/>
<person name="Xiao P."/>
<person name="Xu Y."/>
<person name="Liang Z."/>
<person name="Liu C."/>
<person name="Wang H."/>
<person name="Wang W."/>
<person name="Zheng W."/>
<person name="Zhang W."/>
<person name="Ma X."/>
<person name="He D."/>
<person name="Song X."/>
<person name="Cui F."/>
<person name="Xu Z."/>
<person name="Yi F."/>
<person name="Sun J.P."/>
<person name="Yu X."/>
</authorList>
<dbReference type="PubMed" id="27134172"/>
<dbReference type="DOI" id="10.1016/j.celrep.2016.04.016"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-1112; TYR-1139; TYR-1196 AND TYR-1248</scope>
<scope>DEPHOSPHORYLATION BY PTPN12</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="36422" last="36427">
<title>Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide.</title>
<authorList>
<person name="Kuhns J.J."/>
<person name="Batalia M.A."/>
<person name="Yan S."/>
<person name="Collins E.J."/>
</authorList>
<dbReference type="PubMed" id="10593938"/>
<dbReference type="DOI" id="10.1074/jbc.274.51.36422"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 654-662 IN COMPLEX WITH HLA AND BETA-2 MICROGLOBULIN</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="1399" last="1402">
<title>Novel mode of ligand recognition by the Erbin PDZ domain.</title>
<authorList>
<person name="Birrane G."/>
<person name="Chung J."/>
<person name="Ladias J.A."/>
</authorList>
<dbReference type="PubMed" id="12444095"/>
<dbReference type="DOI" id="10.1074/jbc.C200571200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.25 ANGSTROMS) OF 1247-1255 IN COMPLEX WITH ERBIN</scope>
<scope>INTERACTION WITH ERBIN</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2003" name="J. Biomol. NMR" volume="27" first="205" last="219">
<title>Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.</title>
<authorList>
<person name="Ivancic M."/>
<person name="Daly R.J."/>
<person name="Lyons B.A."/>
</authorList>
<dbReference type="PubMed" id="12975581"/>
<dbReference type="DOI" id="10.1023/A:1025498409113"/>
</citation>
<scope>STRUCTURE BY NMR OF 1135-1144 IN COMPLEX WITH GRB7</scope>
<scope>INTERACTION WITH GRB7</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2003" name="Nature" volume="421" first="756" last="760">
<title>Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab.</title>
<authorList>
<person name="Cho H.-S."/>
<person name="Mason K."/>
<person name="Ramyar K.X."/>
<person name="Stanley A.M."/>
<person name="Gabelli S.B."/>
<person name="Denney D.W. Jr."/>
<person name="Leahy D.J."/>
</authorList>
<dbReference type="PubMed" id="12610629"/>
<dbReference type="DOI" id="10.1038/nature01392"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.52 ANGSTROMS) OF 23-629 IN COMPLEX WITH THE ANTIBODY HERCEPTIN</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2004" name="Cancer Cell" volume="5" first="317" last="328">
<title>Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex.</title>
<authorList>
<person name="Franklin M.C."/>
<person name="Carey K.D."/>
<person name="Vajdos F.F."/>
<person name="Leahy D.J."/>
<person name="de Vos A.M."/>
<person name="Sliwkowski M.X."/>
</authorList>
<dbReference type="PubMed" id="15093539"/>
<dbReference type="DOI" id="10.1016/S1535-6108(04)00083-2"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.25 ANGSTROMS) OF 23-646 IN COMPLEX WITH THE ANTIBODY PERTUZUMAB</scope>
<scope>INTERACTION WITH ERBB3</scope>
<scope>MUTAGENESIS OF 317-LEU-HIS-318</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-187; ASN-259 AND ASN-530</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2009" name="Science" volume="323" first="1610" last="1614">
<title>Variants of the antibody herceptin that interact with HER2 and VEGF at the antigen binding site.</title>
<authorList>
<person name="Bostrom J."/>
<person name="Yu S.F."/>
<person name="Kan D."/>
<person name="Appleton B.A."/>
<person name="Lee C.V."/>
<person name="Billeci K."/>
<person name="Man W."/>
<person name="Peale F."/>
<person name="Ross S."/>
<person name="Wiesmann C."/>
<person name="Fuh G."/>
</authorList>
<dbReference type="PubMed" id="19299620"/>
<dbReference type="DOI" id="10.1126/science.1165480"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 23-646 IN COMPLEX WITH THE ANTIBODY HERCEPTIN</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-259 AND ASN-530</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Proc. Natl. Acad. Sci. U.S.A." volume="107" first="15039" last="15044">
<title>Structural basis for high-affinity HER2 receptor binding by an engineered protein.</title>
<authorList>
<person name="Eigenbrot C."/>
<person name="Ultsch M."/>
<person name="Dubnovitsky A."/>
<person name="Abrahmsen L."/>
<person name="Hard T."/>
</authorList>
<dbReference type="PubMed" id="20696930"/>
<dbReference type="DOI" id="10.1073/pnas.1005025107"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 23-646 IN COMPLEX WITH ENGINEERED ANTIBODY ZHER2</scope>
<scope>DISULFIDE BONDS</scope>
<scope>GLYCOSYLATION AT ASN-68; ASN-259 AND ASN-571</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="18756" last="18765">
<title>Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein.</title>
<authorList>
<person name="Aertgeerts K."/>
<person name="Skene R."/>
<person name="Yano J."/>
<person name="Sang B.C."/>
<person name="Zou H."/>
<person name="Snell G."/>
<person name="Jennings A."/>
<person name="Iwamoto K."/>
<person name="Habuka N."/>
<person name="Hirokawa A."/>
<person name="Ishikawa T."/>
<person name="Tanaka T."/>
<person name="Miki H."/>
<person name="Ohta Y."/>
<person name="Sogabe S."/>
</authorList>
<dbReference type="PubMed" id="21454582"/>
<dbReference type="DOI" id="10.1074/jbc.M110.206193"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 703-1029 IN COMPLEX WITH INHIBITOR SYR127063</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1993" name="Genomics" volume="15" first="426" last="429">
<title>Characterization of a new allele of the human ERBB2 gene by allele-specific competition hybridization.</title>
<authorList>
<person name="Ehsani A."/>
<person name="Low J."/>
<person name="Wallace R.B."/>
<person name="Wu A.M."/>
</authorList>
<dbReference type="PubMed" id="8095488"/>
<dbReference type="DOI" id="10.1006/geno.1993.1081"/>
</citation>
<scope>VARIANTS VAL-654 AND VAL-655</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2004" name="Nature" volume="431" first="525" last="526">
<title>Lung cancer: intragenic ERBB2 kinase mutations in tumours.</title>
<authorList>
<consortium name="Cancer genome project and collaborative group"/>
<person name="Stephens P."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Edkins S."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Stevens C."/>
<person name="O'Meara S."/>
<person name="Smith R."/>
<person name="Parker A."/>
<person name="Barthorpe A."/>
<person name="Blow M."/>
<person name="Brackenbury L."/>
<person name="Butler A."/>
<person name="Clarke O."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Dike A."/>
<person name="Drozd A."/>
<person name="Edwards K."/>
<person name="Forbes S."/>
<person name="Foster R."/>
<person name="Gray K."/>
<person name="Greenman C."/>
<person name="Halliday K."/>
<person name="Hills K."/>
<person name="Kosmidou V."/>
<person name="Lugg R."/>
<person name="Menzies A."/>
<person name="Perry J."/>
<person name="Petty R."/>
<person name="Raine K."/>
<person name="Ratford L."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Stephens Y."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Brasseur F."/>
<person name="Cooper C.S."/>
<person name="Flanagan A.M."/>
<person name="Knowles M."/>
<person name="Leung S.Y."/>
<person name="Louis D.N."/>
<person name="Looijenga L.H."/>
<person name="Malkowicz B."/>
<person name="Pierotti M.A."/>
<person name="Teh B."/>
<person name="Chenevix-Trench G."/>
<person name="Weber B.L."/>
<person name="Yuen S.T."/>
<person name="Harris G."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Futreal P.A."/>
<person name="Wooster R."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="15457249"/>
<dbReference type="DOI" id="10.1038/431525b"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
<scope>VARIANT GASC SER-776</scope>
<scope>VARIANT OC SER-857</scope>
<scope>VARIANT GLM LYS-914</scope>
<scope>VARIANTS LNCR PRO-755; ALA-TYR-VAL-MET-774 INS AND VAL-GLY-SER-779 INS</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] VAL-654; VAL-655; SER-768; ALA-1170 AND ASP-1216</scope>
<scope>VARIANT GASC SER-776</scope>
<scope>VARIANT OC SER-857</scope>
</reference>
<comment type="function">
<text evidence="59">Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization.</text>
</comment>
<comment type="function">
<text evidence="29 36 50">In the nucleus is involved in transcriptional regulation. Associates with the 5'-TCAAATTC-3' sequence in the PTGS2/COX-2 promoter and activates its transcription. Implicated in transcriptional activation of CDKN1A; the function involves STAT3 and SRC. Involved in the transcription of rRNA genes by RNA Pol I and enhances protein synthesis and cell growth.</text>
</comment>
<comment type="catalytic activity">
<text evidence="28 49">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="43 49">Activated by dimerization. Not activated by EGF, TGF-alpha and amphiregulin. Interaction with PTK6 increases its intrinsic kinase activity.</text>
</comment>
<comment type="subunit">
<text evidence="25 29 30 31 32 33 34 35 38 40 43 45 48 49 50 51">Homodimer (PubMed:21454582). Heterodimer with EGFR, ERBB3 and ERBB4 (PubMed:10358079, PubMed:15093539, PubMed:21190959, PubMed:16978839). Part of a complex with EGFR and either PIK3C2A or PIK3C2B. May interact with PIK3C2B when phosphorylated on Tyr-1196 (PubMed:10805725). Interacts with PLXNB1 (PubMed:15210733). Interacts (when phosphorylated on Tyr-1248) with MEMO1 (PubMed:15156151). Interacts with MUC1; the interaction is enhanced by heregulin (HRG) (PubMed:12939402). Interacts (when phosphorylated on Tyr-1139) with GRB7 (via SH2 domain) (PubMed:12975581). Interacts (when phosphorylated on Tyr-1248) with ERBIN (PubMed:12444095). Interacts with KPNB1, RANBP2, EEA1, CRM1 and CLTC (PubMed:16314522). Interacts with PTK6 (PubMed:18719096). Interacts with RPA194 and ACTB (PubMed:21555369). Interacts with PRKCABP, SRC and MYOC (By similarity). Interacts (preferentially with the tyrosine phosphorylated form) with CPNE3; this interaction occurs at the cell membrane and is increased in a growth factor heregulin-dependent manner (PubMed:20010870). Interacts with HSP90AA1 and HSP90AB1 in an ATP-dependent manner; the interaction suppresses ERBB2 kinase activity (PubMed:26517842).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-641062"/>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-375543">
<id>P00519</id>
<label>ABL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1102694">
<id>P42684</id>
<label>ABL2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1222012">
<id>P15309</id>
<label>ACPP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-353944">
<id>P60709</id>
<label>ACTB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1048612">
<id>Q92625</id>
<label>ANKS1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-81694">
<id>O00213</id>
<label>APBB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-702336">
<id>O75815</id>
<label>BCAR3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-617866">
<id>Q9NSE2</id>
<label>CISH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-7878194">
<id>Q7Z7G1</id>
<label>CLNK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-910">
<id>P46109</id>
<label>CRKL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1384360">
<id>Q99704</id>
<label>DOK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-6918542">
<id>Q8TEW6</id>
<label>DOK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-298113">
<id>Q15075</id>
<label>EEA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-538287">
<id>P98172</id>
<label>EFNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-297353">
<id>P00533</id>
<label>EGFR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>21</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-720706">
<id>P21860</id>
<label>ERBB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>25</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-80371">
<id>Q15303</id>
<label>ERBB4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2941912">
<id>Q9UJM3</id>
<label>ERRFI1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1383732">
<id>P09769</id>
<label>FGR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-515315">
<id>P06241</id>
<label>FYN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-740418">
<id>O75791</id>
<label>GRAP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-970191">
<id>Q14451</id>
<label>GRB7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2868511">
<id>O75367</id>
<label>H2AFY</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-6250866">
<id>O75367-3</id>
<label>H2AFY</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-296047">
<id>P07900</id>
<label>HSP90AA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-352572">
<id>P08238</id>
<label>HSP90AB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-297509">
<id>P46940</id>
<label>IQGAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-517592">
<id>P35568</id>
<label>IRS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-968552">
<id>Q08881</id>
<label>ITK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1383438">
<id>P23458</id>
<label>JAK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-286758">
<id>Q14974</id>
<label>KPNB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
<label>MAPK8IP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-722813">
<id>Q13387</id>
<label>MAPK8IP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-751664">
<id>P42679</id>
<label>MATK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1104564">
<id>Q9Y316</id>
<label>MEMO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-713635">
<id>O43639</id>
<label>NCK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2460927">
<id>Q02297-7</id>
<label>NRG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-641107">
<id>O00750</id>
<label>PIK3C2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-79464">
<id>P27986</id>
<label>PIK3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-346930">
<id>O00459</id>
<label>PIK3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-79893">
<id>Q92569</id>
<label>PIK3R3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-79387">
<id>P19174</id>
<label>PLCG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-617403">
<id>P16885</id>
<label>PLCG2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-359472">
<id>O95602</id>
<label>POLR1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>16</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-702142">
<id>Q05397</id>
<label>PTK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1383632">
<id>Q13882</id>
<label>PTK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-297779">
<id>Q06124</id>
<label>PTPN11</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2266035">
<id>Q05209</id>
<label>PTPN12</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1384210">
<id>Q99952</id>
<label>PTPN18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-12739708">
<id>Q99952-1</id>
<label>PTPN18</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1265766">
<id>P23467</id>
<label>PTPRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1341">
<id>P08575</id>
<label>PTPRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2264500">
<id>Q12913</id>
<label>PTPRJ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-474052">
<id>Q15262</id>
<label>PTPRK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-723739">
<id>Q16827</id>
<label>PTPRO</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-973138">
<id>P49792</id>
<label>RANBP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1026476">
<id>P20936</id>
<label>RASA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2823742">
<id>O95980</id>
<label>RECK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-490630">
<id>Q9NP31</id>
<label>SH2D2A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-78835">
<id>P29353</id>
<label>SHC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-7256023">
<id>P98077</id>
<label>SHC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-79084">
<id>Q92529</id>
<label>SHC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1222854">
<id>Q9H6Q3</id>
<label>SLA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-968198">
<id>O15524</id>
<label>SOCS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-621482">
<id>P12931</id>
<label>SRC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1057697">
<id>P42224</id>
<label>STAT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2515547">
<id>Q7KZ85</id>
<label>SUPT6H</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-78302">
<id>P43405</id>
<label>SYK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-2462036">
<id>Q9Y490</id>
<label>TLN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-949753">
<id>Q63HR2</id>
<label>TNS2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-1220488">
<id>Q68CZ2</id>
<label>TNS3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-7875353">
<id>Q96D37</id>
<label>VAV1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-297549">
<id>P52735</id>
<label>VAV2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-641062"/>
<interactant intactId="EBI-355867">
<id>O14980</id>
<label>XPO1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location>Cell membrane</location>
<topology>Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Translocation to the nucleus requires endocytosis, probably endosomal sorting and is mediated by importin beta-1/KPNB1.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="subcellular location">
<molecule>Isoform 3</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>P04626-1</id>
<name>1</name>
<name>ERBB2</name>
<name>HER2</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P04626-2</id>
<name>2</name>
<name>CTF-611</name>
<sequence type="described" ref="VSP_039249"/>
<text>Produced by alternative initiation at Met-611 of isoform 1.</text>
</isoform>
<isoform>
<id>P04626-3</id>
<name>3</name>
<name>CTF-687</name>
<sequence type="described" ref="VSP_039250"/>
<text>Produced by alternative initiation at Met-687 of isoform 1.</text>
</isoform>
<isoform>
<id>P04626-4</id>
<name>4</name>
<sequence type="described" ref="VSP_039248"/>
<text>Produced by alternative splicing of isoform 1.</text>
</isoform>
<isoform>
<id>P04626-5</id>
<name>5</name>
<sequence type="described" ref="VSP_054787"/>
<text>No experimental confirmation available. Gene prediction based on partial mRNA and EST data.</text>
</isoform>
<isoform>
<id>P04626-6</id>
<name>6</name>
<name>B</name>
<sequence type="described" ref="VSP_055902 VSP_055903 VSP_055904"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="36">Expressed in a variety of tumor tissues including primary breast tumors and tumors from small bowel, esophagus, kidney and mouth.</text>
</comment>
<comment type="PTM">
<text evidence="42 52 59">Autophosphorylated. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit (Probable). Ligand-binding increases phosphorylation on tyrosine residues (PubMed:27134172). Signaling via SEMA4C promotes phosphorylation at Tyr-1248 (PubMed:17554007). Dephosphorylated by PTPN12 (PubMed:27134172).</text>
</comment>
<comment type="polymorphism">
<text>There are four alleles due to the variations in positions 654 and 655. Allele B1 (Ile-654/Ile-655) has a frequency of 0.782; allele B2 (Ile-654/Val-655) has a frequency of 0.206; allele B3 (Val-654/Val-655) has a frequency of 0.012.</text>
</comment>
<comment type="disease" evidence="37">
<disease id="DI-02566">
<name>Glioma</name>
<acronym>GLM</acronym>
<description>Gliomas are benign or malignant central nervous system neoplasms derived from glial cells. They comprise astrocytomas and glioblastoma multiforme that are derived from astrocytes, oligodendrogliomas derived from oligodendrocytes and ependymomas derived from ependymocytes.</description>
<dbReference type="MIM" id="137800"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="37 41">
<disease id="DI-01655">
<name>Ovarian cancer</name>
<acronym>OC</acronym>
<description>The term ovarian cancer defines malignancies originating from ovarian tissue. Although many histologic types of ovarian tumors have been described, epithelial ovarian carcinoma is the most common form. Ovarian cancers are often asymptomatic and the recognized signs and symptoms, even of late-stage disease, are vague. Consequently, most patients are diagnosed with advanced disease.</description>
<dbReference type="MIM" id="167000"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="37">
<disease id="DI-02205">
<name>Lung cancer</name>
<acronym>LNCR</acronym>
<description>A common malignancy affecting tissues of the lung. The most common form of lung cancer is non-small cell lung cancer (NSCLC) that can be divided into 3 major histologic subtypes: squamous cell carcinoma, adenocarcinoma, and large cell lung cancer. NSCLC is often diagnosed at an advanced stage and has a poor prognosis.</description>
<dbReference type="MIM" id="211980"/>
</disease>
<text>The gene represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease" evidence="37 41">
<disease id="DI-02971">
<name>Gastric cancer</name>
<acronym>GASC</acronym>
<description>A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease.</description>
<dbReference type="MIM" id="613659"/>
</disease>
<text>The protein represented in this entry is involved in disease pathogenesis.</text>
</comment>
<comment type="disease">
<text evidence="47">Chromosomal aberrations involving ERBB2 may be a cause gastric cancer. Deletions within 17q12 region producing fusion transcripts with CDK12, leading to CDK12-ERBB2 fusion leading to truncated CDK12 protein not in-frame with ERBB2.</text>
</comment>
<comment type="similarity">
<text evidence="27">Belongs to the protein kinase superfamily. Tyr protein kinase family. EGF receptor subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/ERBB2ID162ch17q11.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/erbb2/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/ERBB2"/>
<text>ERBB2 entry</text>
</comment>
<dbReference type="EC" id="2.7.10.1"/>
<dbReference type="EMBL" id="AH001455">
<property type="protein sequence ID" value="AAA35808.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X03363">
<property type="protein sequence ID" value="CAA27060.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M11730">
<property type="protein sequence ID" value="AAA75493.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M12036">
<property type="protein sequence ID" value="AAA35978.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY208911">
<property type="protein sequence ID" value="AAO18082.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK295195">
<property type="protein sequence ID" value="BAG58195.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471152">
<property type="protein sequence ID" value="EAW60597.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC167147">
<property type="protein sequence ID" value="AAI67147.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M16792">
<property type="protein sequence ID" value="AAA58637.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M16789">
<property type="protein sequence ID" value="AAA58637.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M16790">
<property type="protein sequence ID" value="AAA58637.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M16791">
<property type="protein sequence ID" value="AAA58637.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="KJ534964">
<property type="protein sequence ID" value="AHW56604.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L29395">
<property type="protein sequence ID" value="AAA35809.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M95667">
<property type="protein sequence ID" value="AAC37531.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32642.1">
<molecule id="P04626-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45667.1">
<molecule id="P04626-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74052.1">
<molecule id="P04626-4"/>
</dbReference>
<dbReference type="PIR" id="A24571">
<property type="entry name" value="A24571"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001005862.1">
<molecule id="P04626-5"/>
<property type="nucleotide sequence ID" value="NM_001005862.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276865.1">
<molecule id="P04626-4"/>
<property type="nucleotide sequence ID" value="NM_001289936.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276867.1">
<property type="nucleotide sequence ID" value="NM_001289938.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004439.2">
<molecule id="P04626-1"/>
<property type="nucleotide sequence ID" value="NM_004448.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.446352"/>
<dbReference type="PDB" id="1MFG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.25"/>
<property type="chains" value="B=1247-1255"/>
</dbReference>
<dbReference type="PDB" id="1MFL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.88"/>
<property type="chains" value="B=1247-1255"/>
</dbReference>
<dbReference type="PDB" id="1MW4">
<property type="method" value="NMR"/>
<property type="chains" value="B=1135-1144"/>
</dbReference>
<dbReference type="PDB" id="1N8Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="C=23-629"/>
</dbReference>
<dbReference type="PDB" id="1OVC">
<property type="method" value="Model"/>
<property type="chains" value="A=737-1031"/>
</dbReference>
<dbReference type="PDB" id="1QR1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="C/F=654-662"/>
</dbReference>
<dbReference type="PDB" id="1S78">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A/B=23-646"/>
</dbReference>
<dbReference type="PDB" id="2A91">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=22-530"/>
</dbReference>
<dbReference type="PDB" id="2JWA">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=641-684"/>
</dbReference>
<dbReference type="PDB" id="2KS1">
<property type="method" value="NMR"/>
<property type="chains" value="A=641-684"/>
</dbReference>
<dbReference type="PDB" id="2L4K">
<property type="method" value="NMR"/>
<property type="chains" value="B=1135-1144"/>
</dbReference>
<dbReference type="PDB" id="2N2A">
<property type="method" value="NMR"/>
<property type="chains" value="A/B=644-700"/>
</dbReference>
<dbReference type="PDB" id="3BE1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=23-646"/>
</dbReference>
<dbReference type="PDB" id="3H3B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/B=23-214"/>
</dbReference>
<dbReference type="PDB" id="3MZW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A=23-646"/>
</dbReference>
<dbReference type="PDB" id="3N85">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A=23-646"/>
</dbReference>
<dbReference type="PDB" id="3PP0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B=703-1009"/>
</dbReference>
<dbReference type="PDB" id="3RCD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.21"/>
<property type="chains" value="A/B/C/D=713-1028"/>
</dbReference>
<dbReference type="PDB" id="3WLW">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.09"/>
<property type="chains" value="A/B=23-586"/>
</dbReference>
<dbReference type="PDB" id="3WSQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A=23-586"/>
</dbReference>
<dbReference type="PDB" id="4GFU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="F=1246-1252"/>
</dbReference>
<dbReference type="PDB" id="4HRL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="C=24-219"/>
</dbReference>
<dbReference type="PDB" id="4HRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/C=24-219"/>
</dbReference>
<dbReference type="PDB" id="4HRN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="C/D=529-625"/>
</dbReference>
<dbReference type="PDBsum" id="1MFG"/>
<dbReference type="PDBsum" id="1MFL"/>
<dbReference type="PDBsum" id="1MW4"/>
<dbReference type="PDBsum" id="1N8Z"/>
<dbReference type="PDBsum" id="1OVC"/>
<dbReference type="PDBsum" id="1QR1"/>
<dbReference type="PDBsum" id="1S78"/>
<dbReference type="PDBsum" id="2A91"/>
<dbReference type="PDBsum" id="2JWA"/>
<dbReference type="PDBsum" id="2KS1"/>
<dbReference type="PDBsum" id="2L4K"/>
<dbReference type="PDBsum" id="2N2A"/>
<dbReference type="PDBsum" id="3BE1"/>
<dbReference type="PDBsum" id="3H3B"/>
<dbReference type="PDBsum" id="3MZW"/>
<dbReference type="PDBsum" id="3N85"/>
<dbReference type="PDBsum" id="3PP0"/>
<dbReference type="PDBsum" id="3RCD"/>
<dbReference type="PDBsum" id="3WLW"/>
<dbReference type="PDBsum" id="3WSQ"/>
<dbReference type="PDBsum" id="4GFU"/>
<dbReference type="PDBsum" id="4HRL"/>
<dbReference type="PDBsum" id="4HRM"/>
<dbReference type="PDBsum" id="4HRN"/>
<dbReference type="ProteinModelPortal" id="P04626"/>
<dbReference type="SMR" id="P04626"/>
<dbReference type="BioGrid" id="108376">
<property type="interactions" value="176"/>
</dbReference>
<dbReference type="DIP" id="DIP-8N"/>
<dbReference type="IntAct" id="P04626">
<property type="interactions" value="248"/>
</dbReference>
<dbReference type="MINT" id="MINT-158636"/>
<dbReference type="STRING" id="9606.ENSP00000269571"/>
<dbReference type="BindingDB" id="P04626"/>
<dbReference type="ChEMBL" id="CHEMBL1824"/>
<dbReference type="DrugBank" id="DB08916">
<property type="generic name" value="Afatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB04988">
<property type="generic name" value="IGN311"/>
</dbReference>
<dbReference type="DrugBank" id="DB01259">
<property type="generic name" value="Lapatinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB06366">
<property type="generic name" value="Pertuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB00072">
<property type="generic name" value="Trastuzumab"/>
</dbReference>
<dbReference type="DrugBank" id="DB05773">
<property type="generic name" value="Trastuzumab emtansine"/>
</dbReference>
<dbReference type="DrugBank" id="DB05007">
<property type="generic name" value="XL647"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2019"/>
<dbReference type="iPTMnet" id="P04626"/>
<dbReference type="PhosphoSitePlus" id="P04626"/>
<dbReference type="BioMuta" id="ERBB2"/>
<dbReference type="DMDM" id="119533"/>
<dbReference type="EPD" id="P04626"/>
<dbReference type="PaxDb" id="P04626"/>
<dbReference type="PeptideAtlas" id="P04626"/>
<dbReference type="PRIDE" id="P04626"/>
<dbReference type="DNASU" id="2064"/>
<dbReference type="Ensembl" id="ENST00000269571">
<molecule id="P04626-1"/>
<property type="protein sequence ID" value="ENSP00000269571"/>
<property type="gene ID" value="ENSG00000141736"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000406381">
<molecule id="P04626-5"/>
<property type="protein sequence ID" value="ENSP00000385185"/>
<property type="gene ID" value="ENSG00000141736"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000541774">
<molecule id="P04626-4"/>
<property type="protein sequence ID" value="ENSP00000446466"/>
<property type="gene ID" value="ENSG00000141736"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000584601">
<molecule id="P04626-5"/>
<property type="protein sequence ID" value="ENSP00000462438"/>
<property type="gene ID" value="ENSG00000141736"/>
</dbReference>
<dbReference type="GeneID" id="2064"/>
<dbReference type="KEGG" id="hsa:2064"/>
<dbReference type="UCSC" id="uc060esv.1">
<molecule id="P04626-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2064"/>
<dbReference type="DisGeNET" id="2064"/>
<dbReference type="GeneCards" id="ERBB2"/>
<dbReference type="HGNC" id="HGNC:3430">
<property type="gene designation" value="ERBB2"/>
</dbReference>
<dbReference type="HPA" id="CAB000043"/>
<dbReference type="HPA" id="CAB020416"/>
<dbReference type="HPA" id="CAB062555"/>
<dbReference type="HPA" id="HPA001060"/>
<dbReference type="HPA" id="HPA001338"/>
<dbReference type="HPA" id="HPA001383"/>
<dbReference type="MalaCards" id="ERBB2"/>
<dbReference type="MIM" id="137800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="164870">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="167000">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="211980">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="613659">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P04626"/>
<dbReference type="OpenTargets" id="ENSG00000141736"/>
<dbReference type="PharmGKB" id="PA27844"/>
<dbReference type="eggNOG" id="KOG1025">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNSR">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118799"/>
<dbReference type="HOGENOM" id="HOG000230982"/>
<dbReference type="HOVERGEN" id="HBG000490"/>
<dbReference type="InParanoid" id="P04626"/>
<dbReference type="KO" id="K05083"/>
<dbReference type="OMA" id="ACYPLCA"/>
<dbReference type="OrthoDB" id="EOG091G00NO"/>
<dbReference type="PhylomeDB" id="P04626"/>
<dbReference type="TreeFam" id="TF106002"/>
<dbReference type="BRENDA" id="2.7.10.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1227986">
<property type="pathway name" value="Signaling by ERBB2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1250196">
<property type="pathway name" value="SHC1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1251932">
<property type="pathway name" value="PLCG1 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1306955">
<property type="pathway name" value="GRB7 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1358803">
<property type="pathway name" value="Downregulation of ERBB2:ERBB3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963640">
<property type="pathway name" value="GRB2 events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1963642">
<property type="pathway name" value="PI3K events in ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-416572">
<property type="pathway name" value="Sema4D induced cell migration and growth-cone collapse"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673001">
<property type="pathway name" value="RAF/MAP kinase cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6785631">
<property type="pathway name" value="ERBB2 Regulates Cell Motility"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8847993">
<property type="pathway name" value="ERBB2 Activates PTK6 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8863795">
<property type="pathway name" value="Downregulation of ERBB2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8866910">
<property type="pathway name" value="TFAP2 (AP-2) family regulates transcription of growth factors and their receptors"/>
</dbReference>
<dbReference type="SignaLink" id="P04626"/>
<dbReference type="SIGNOR" id="P04626"/>
<dbReference type="ChiTaRS" id="ERBB2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P04626"/>
<dbReference type="GeneWiki" id="HER2/neu"/>
<dbReference type="GenomeRNAi" id="2064"/>
<dbReference type="PMAP-CutDB" id="P04626"/>
<dbReference type="PRO" id="PR:P04626"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000141736"/>
<dbReference type="CleanEx" id="HS_ERBB2"/>
<dbReference type="ExpressionAtlas" id="P04626">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P04626">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016324">
<property type="term" value="C:apical plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043209">
<property type="term" value="C:myelin sheath"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043125">
<property type="term" value="F:ErbB-3 class receptor binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005088">
<property type="term" value="F:Ras guanyl-nucleotide exchange factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0001042">
<property type="term" value="F:RNA polymerase I core binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004716">
<property type="term" value="F:signal transducer, downstream of receptor, with protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004714">
<property type="term" value="F:transmembrane receptor protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071363">
<property type="term" value="P:cellular response to growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007167">
<property type="term" value="P:enzyme linked receptor protein signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0038128">
<property type="term" value="P:ERBB2 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008045">
<property type="term" value="P:motor neuron axon guidance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042552">
<property type="term" value="P:myelination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901185">
<property type="term" value="P:negative regulation of ERBB signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033088">
<property type="term" value="P:negative regulation of immature T cell proliferation in thymus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007528">
<property type="term" value="P:neuromuscular junction development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048709">
<property type="term" value="P:oligodendrocyte differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007422">
<property type="term" value="P:peripheral nervous system development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048015">
<property type="term" value="P:phosphatidylinositol-mediated signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045785">
<property type="term" value="P:positive regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050679">
<property type="term" value="P:positive regulation of epithelial cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043547">
<property type="term" value="P:positive regulation of GTPase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043406">
<property type="term" value="P:positive regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090314">
<property type="term" value="P:positive regulation of protein targeting to membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045943">
<property type="term" value="P:positive regulation of transcription from RNA polymerase I promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045945">
<property type="term" value="P:positive regulation of transcription from RNA polymerase III promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045727">
<property type="term" value="P:positive regulation of translation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045765">
<property type="term" value="P:regulation of angiogenesis"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000145">
<property type="term" value="P:regulation of cell motility"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070372">
<property type="term" value="P:regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032886">
<property type="term" value="P:regulation of microtubule-based process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007169">
<property type="term" value="P:transmembrane receptor protein tyrosine kinase signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="3.80.20.20">
<property type="match status" value="3"/>
</dbReference>
<dbReference type="InterPro" id="IPR006211">
<property type="entry name" value="Furin-like_Cys-rich_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR006212">
<property type="entry name" value="Furin_repeat"/>
</dbReference>
<dbReference type="InterPro" id="IPR032778">
<property type="entry name" value="GF_recep_IV"/>
</dbReference>
<dbReference type="InterPro" id="IPR009030">
<property type="entry name" value="Growth_fac_rcpt_"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR032675">
<property type="entry name" value="L_dom-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000494">
<property type="entry name" value="Rcpt_L-dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008266">
<property type="entry name" value="Tyr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR020635">
<property type="entry name" value="Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR016245">
<property type="entry name" value="Tyr_kinase_EGF/ERB/XmrK_rcpt"/>
</dbReference>
<dbReference type="Pfam" id="PF00757">
<property type="entry name" value="Furin-like"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF14843">
<property type="entry name" value="GF_recep_IV"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01030">
<property type="entry name" value="Recep_L_domain"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000619">
<property type="entry name" value="TyrPK_EGF-R"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00261">
<property type="entry name" value="FU"/>
<property type="match status" value="3"/>
</dbReference>
<dbReference type="SMART" id="SM00219">
<property type="entry name" value="TyrKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52058">
<property type="entry name" value="SSF52058"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57184">
<property type="entry name" value="SSF57184"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00109">
<property type="entry name" value="PROTEIN_KINASE_TYR"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="signal peptide" evidence="26">
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="chain" description="Receptor tyrosine-protein kinase erbB-2" id="PRO_0000016669">
<location>
<begin position="23"/>
<end position="1255"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="26">
<location>
<begin position="23"/>
<end position="652"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="26">
<location>
<begin position="653"/>
<end position="675"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="26">
<location>
<begin position="676"/>
<end position="1255"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="27">
<location>
<begin position="720"/>
<end position="987"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="27">
<location>
<begin position="726"/>
<end position="734"/>
</location>
</feature>
<feature type="region of interest" description="Required for interaction with KPNB1 and EEA1" evidence="38">
<location>
<begin position="676"/>
<end position="689"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PIK3C2B" evidence="59">
<location>
<begin position="1195"/>
<end position="1197"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="676"/>
<end position="689"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="27 28">
<location>
<position position="845"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="27">
<location>
<position position="753"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="22">
<location>
<position position="182"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="18 19 21 22 23">
<location>
<position position="1054"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="24">
<location>
<position position="1078"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="22">
<location>
<position position="1083"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="20">
<location>
<position position="1107"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="52">
<location>
<position position="1112"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="52">
<location>
<position position="1139"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="23">
<location>
<position position="1151"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="22">
<location>
<position position="1166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="52">
<location>
<position position="1196"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="17 42 52">
<location>
<position position="1248"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="4 9 46">
<location>
<position position="68"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="26">
<location>
<position position="124"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2 3 4 10 26">
<location>
<position position="187"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="2 3 4 9 10 33 44 46">
<location>
<position position="259"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="3 33 44">
<location>
<position position="530"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="9 46">
<location>
<position position="571"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="26">
<location>
<position position="629"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 8 9 10 12 13 14 15">
<location>
<begin position="26"/>
<end position="53"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 8 9 10 12 13 14 15">
<location>
<begin position="162"/>
<end position="192"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 8 9 10 12 13 14 15">
<location>
<begin position="195"/>
<end position="204"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 8 9 10 12 13 14 15">
<location>
<begin position="199"/>
<end position="212"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="220"/>
<end position="227"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="224"/>
<end position="235"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="236"/>
<end position="244"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="240"/>
<end position="252"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="255"/>
<end position="264"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="268"/>
<end position="295"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="299"/>
<end position="311"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="315"/>
<end position="331"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="334"/>
<end position="338"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="342"/>
<end position="367"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="475"/>
<end position="504"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="511"/>
<end position="520"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 7 9 10 12 13">
<location>
<begin position="515"/>
<end position="528"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 7 9 10 12 13 16">
<location>
<begin position="531"/>
<end position="540"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 7 9 10 12 13 16">
<location>
<begin position="544"/>
<end position="560"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 7 9 10 12 13 16">
<location>
<begin position="563"/>
<end position="576"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 7 9 10 12 13 16">
<location>
<begin position="567"/>
<end position="584"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 7 9 10 16">
<location>
<begin position="587"/>
<end position="596"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 7 10">
<location>
<begin position="600"/>
<end position="623"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="626"/>
<end position="634"/>
</location>
</feature>
<feature type="disulfide bond" evidence="10">
<location>
<begin position="630"/>
<end position="642"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_039250" evidence="59">
<location>
<begin position="1"/>
<end position="686"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_039249" evidence="59">
<location>
<begin position="1"/>
<end position="610"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_054787" evidence="59">
<location>
<begin position="1"/>
<end position="30"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_039248" evidence="58">
<original>MELAALCRWGLLLALLPPGAAST</original>
<variation>MPRGSWKP</variation>
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_055902" evidence="57">
<location>
<begin position="633"/>
<end position="648"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_055903" evidence="57">
<original>AYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK</original>
<variation>TISNLFSNFAPRGPSACCEPTCWCHSGKGQDSLPREEWGRQRRFCLWGCRGEPRVLDTPGRSCPSAPPSSCLQPSLRQPLLLGPGPTRAGGSTQHLQRDTYGREPRVPGSGRASVNQKAKSAEALMCPQGAGKA</variation>
<location>
<begin position="771"/>
<end position="883"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_055904" evidence="57">
<location>
<begin position="884"/>
<end position="1255"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs4252633." id="VAR_016317" evidence="56">
<original>W</original>
<variation>C</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="In allele B3; dbSNP:rs1801201." id="VAR_004077" evidence="41 54">
<original>I</original>
<variation>V</variation>
<location>
<position position="654"/>
</location>
</feature>
<feature type="sequence variant" description="In allele B2 and allele B3; dbSNP:rs1136201." id="VAR_004078" evidence="41 54 56">
<original>I</original>
<variation>V</variation>
<location>
<position position="655"/>
</location>
</feature>
<feature type="sequence variant" description="In LNCR; somatic mutation; unknown pathological significance; dbSNP:rs121913469." id="VAR_055432" evidence="37">
<original>L</original>
<variation>P</variation>
<location>
<position position="755"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56366519." id="VAR_042097" evidence="41">
<original>L</original>
<variation>S</variation>
<location>
<position position="768"/>
</location>
</feature>
<feature type="sequence variant" description="In LNCR; somatic mutation; unknown pathological significance." id="VAR_055433" evidence="37">
<original>M</original>
<variation>MAYVM</variation>
<location>
<position position="774"/>
</location>
</feature>
<feature type="sequence variant" description="In GASC; somatic mutation; unknown pathological significance; dbSNP:rs28933369." id="VAR_042098" evidence="37 41">
<original>G</original>
<variation>S</variation>
<location>
<position position="776"/>
</location>
</feature>
<feature type="sequence variant" description="In LNCR; somatic mutation; unknown pathological significance." id="VAR_055434" evidence="37">
<original>S</original>
<variation>SVGS</variation>
<location>
<position position="779"/>
</location>
</feature>
<feature type="sequence variant" description="In OC; somatic mutation; unknown pathological significance; dbSNP:rs28933370." id="VAR_042099" evidence="37 41">
<original>N</original>
<variation>S</variation>
<location>
<position position="857"/>
</location>
</feature>
<feature type="sequence variant" description="In GLM; somatic mutation; unknown pathological significance; dbSNP:rs28933368." id="VAR_055435" evidence="37">
<original>E</original>
<variation>K</variation>
<location>
<position position="914"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs61552325." id="VAR_016318" evidence="41 53 55 56">
<original>P</original>
<variation>A</variation>
<location>
<position position="1170"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55943169." id="VAR_042100" evidence="41">
<original>A</original>
<variation>D</variation>
<location>
<position position="1216"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces dimerization with ERBB3." evidence="33">
<original>LH</original>
<variation>AA</variation>
<location>
<begin position="317"/>
<end position="318"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents synthesis of isoform 2." evidence="39">
<original>M</original>
<variation>A</variation>
<location>
<position position="611"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents synthesis of isoform 3." evidence="39">
<original>M</original>
<variation>A</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on isoform production." evidence="39">
<original>M</original>
<variation>A</variation>
<location>
<position position="706"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on isoform production." evidence="39">
<original>M</original>
<variation>A</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="25"/>
<end position="27"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="39"/>
<end position="50"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="54"/>
<end position="58"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="60"/>
<end position="64"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="72"/>
<end position="74"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="79"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="84"/>
<end position="88"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="92"/>
<end position="95"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="112"/>
<end position="117"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="130"/>
<end position="132"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="139"/>
<end position="141"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="150"/>
<end position="156"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="164"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="169"/>
<end position="172"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="175"/>
<end position="177"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="182"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="199"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="204"/>
<end position="208"/>
</location>
</feature>
<feature type="helix" evidence="14">
<location>
<begin position="209"/>
<end position="211"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="217"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="221"/>
<end position="223"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="227"/>
<end position="231"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="232"/>
<end position="234"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="240"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="251"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="263"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="271"/>
<end position="274"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="276"/>
<end position="278"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="281"/>
<end position="283"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="289"/>
<end position="291"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="294"/>
<end position="298"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="309"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="320"/>
<end position="323"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="325"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="329"/>
<end position="332"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="335"/>
<end position="337"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="348"/>
<end position="352"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="358"/>
<end position="360"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="361"/>
<end position="364"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="368"/>
<end position="376"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="378"/>
<end position="382"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="385"/>
<end position="387"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="396"/>
<end position="402"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="405"/>
<end position="408"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="410"/>
<end position="413"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="423"/>
<end position="425"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="430"/>
<end position="435"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="438"/>
<end position="440"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="441"/>
<end position="447"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="463"/>
<end position="469"/>
</location>
</feature>
<feature type="turn" evidence="12">
<location>
<begin position="477"/>
<end position="479"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="482"/>
<end position="485"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="486"/>
<end position="488"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="493"/>
<end position="499"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="501"/>
<end position="506"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="507"/>
<end position="509"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="516"/>
<end position="518"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="520"/>
<end position="524"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="525"/>
<end position="527"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="528"/>
<end position="536"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="539"/>
<end position="542"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="545"/>
<end position="551"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="553"/>
<end position="556"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="559"/>
<end position="562"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="565"/>
<end position="567"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="571"/>
<end position="573"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="575"/>
<end position="580"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="583"/>
<end position="592"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="595"/>
<end position="599"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="602"/>
<end position="604"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="615"/>
<end position="617"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="621"/>
<end position="625"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="628"/>
<end position="632"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="635"/>
<end position="637"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="651"/>
<end position="678"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="684"/>
<end position="690"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="691"/>
<end position="697"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="717"/>
<end position="719"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="720"/>
<end position="728"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="730"/>
<end position="739"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="748"/>
<end position="755"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="761"/>
<end position="774"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="785"/>
<end position="799"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="806"/>
<end position="812"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="814"/>
<end position="816"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="819"/>
<end position="838"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="848"/>
<end position="850"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="851"/>
<end position="855"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="858"/>
<end position="861"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="886"/>
<end position="888"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="891"/>
<end position="896"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="901"/>
<end position="916"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="922"/>
<end position="925"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="928"/>
<end position="930"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="931"/>
<end position="936"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="949"/>
<end position="958"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="963"/>
<end position="965"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="969"/>
<end position="980"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="983"/>
<end position="986"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="989"/>
<end position="992"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="1003"/>
<end position="1007"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1140"/>
<end position="1142"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1MW4"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1N8Z"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1S78"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2A91"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JWA"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2N2A"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BE1"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3H3B"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3MZW"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3N85"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3PP0"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WLW"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3WSQ"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HRL"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HRM"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HRN"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P06494"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P70424"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000255"/>
<evidence key="27" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10028"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10358079"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10805725"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12939402"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12975581"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15093539"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15156151"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15210733"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15380516"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15457249"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16314522"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16794579"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16978839"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17554007"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18719096"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19299620"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20010870"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20696930"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21097718"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21190959"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21454582"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21555369"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26517842"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27134172"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2999974"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8095488"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8104414"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="57" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="24722188"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000303">
<source ref="4"/>
</evidence>
<evidence key="59" type="ECO:0000305"/>
<sequence length="1255" mass="137910" checksum="39E9DFDA04DCF962" modified="1987-08-13" version="1" precursor="true">
MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNL
ELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNG
DPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLA
LTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQC
AAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACP
YNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSAN
IQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLP
DLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTV
PWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQEC
VEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARC
PSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSIISAVVG
ILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLTPSGAMPNQAQMRILKETEL
RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP
YVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR
LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT
HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWM
IDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDA
EEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLAPSEG
AGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYV
NQPDVRPQPPSPREGPLPAARPAGATLERPKTLSPGKNGVVKDVFAFGGAVENPEYLTPQ
GGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>